A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

June 30, 2017

Conditions
Prostate Cancer
Interventions
DRUG

degarelix

Trial Locations (3)

Unknown

Tampereen yliopistollinen sairaala (there may be other sites in this country), Tampere

Groupe Hospitalier Pellegrin Tripode (there may be other sites in this country), Bordeaux

Universitaetsklinikum Freiburg (there may be other sites in this country), Freiburg im Breisgau

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY